As Jiehua Deng et al. identified, m7G may be able to control both CD8+ T cells and regulatory T cells (Treg cells), and they also suggest a connection between m7G and the prognosis of melanoma (Chen et al., 2022; Deng et al., 2022). Here, CD8A is linked to melanoma.